Insulet Corp (PODD)

49.38
NASDAQ : Health Care
Prev Close 48.80
Day Low/High 48.01 / 49.59
52 Wk Low/High 27.62 / 49.59
Avg Volume 429.00K
Exchange NASDAQ
Shares Outstanding 57.92M
Market Cap 2.83B
EPS -0.50
P/E Ratio 90.37
Div & Yield N.A. (N.A)

Latest News

Insulet Corporation To Present At Upcoming Investor Conference

Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at the William Blair & Co.

Insulet Appoints Bret Christensen As Chief Commercial Officer

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced the appointment of Bret Christensen as...

Insulet Corporation Ranked #4 On Forbes 2017 Most Innovative Growth Companies List

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced that it is...

Insulet Reports First Quarter 2017 Financial Results

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced financial results for...

PODD: Insiders vs. Shorts

The most recent short interest data was recently released for the 04/13/2017 settlement date, and Insulet Corp is one of the most shorted stocks of the Russell 3000, based on 12.38 "days to cover" versus the median component at 5.14. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Insulet Corporation To Announce First Quarter 2017 Financial Results On May 8, 2017

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results...

When Very Predictable Is Highly Profitable: Cramer's 'Mad Money' Recap (Wednesday 3/15/17)

When Very Predictable Is Highly Profitable: Cramer's 'Mad Money' Recap (Wednesday 3/15/17)

Jim Cramer says economic fundamentals remain strong and this market's rallying with relief at Fed's anticipated rate hike.

Short Interest Declines 11.2% For PODD

The most recent short interest data has been released for the 02/28/2017 settlement date, which shows a 529,599 share decrease in total short interest for Insulet Corp , to 4,183,973, a decrease of 11.24% since 02/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Insulet Reports Fourth Quarter And Full Year 2016 Financial Results

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced financial results for...

Insulet Presents Strong Omnipod® Horizon™ Hybrid Closed-Loop Study Results At ATTD In Paris

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced positive...

Insulet Reaches Analyst Target Price

In recent trading, shares of Insulet Corp have crossed above the average analyst 12-month target price of $43.39, changing hands for $43.40/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Insulet Completes Acquisition Of U.S. Manufacturing Facility In Acton, Massachusetts

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced the Company has completed the acquisition...

Insulet Corporation To Present At Upcoming Investor Conferences

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at two...

PODD: Insiders vs. Shorts

The most recent short interest data was recently released for the 01/13/2017 settlement date, and Insulet Corp is one of the most shorted stocks of the Russell 3000, based on 6.09 "days to cover" versus the median component at 5.04. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AEUA, APC, CBL, DFRG, EFII, ENR, EPAY, EXTR, HMTV, OCLR, PGEM, PODD, SFLY, TUP Downgrades: CVX, FNFV, OPK Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Insulet Corporation To Announce Fourth Quarter And Full Year 2016 Financial Results On February 27, 2017

Insulet Corporation To Announce Fourth Quarter And Full Year 2016 Financial Results On February 27, 2017

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results...

Insulet Corporation To Present At Upcoming Investor Conference

Insulet Corporation To Present At Upcoming Investor Conference

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at the 35 th...

Insulet Celebrates Milestone Of 100,000 Customers Actively Using The Omnipod® System

Insulet Celebrates Milestone Of 100,000 Customers Actively Using The Omnipod® System

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced it has reached a...

PODD: Insiders vs. Shorts

PODD: Insiders vs. Shorts

The most recent short interest data was recently released for the 10/14/2016 settlement date, and Insulet Corp is one of the most shorted stocks of the Russell 3000, based on 10.73 "days to cover" versus the median component at 6.24. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Analysts' Actions -- Express Scripts, Lions Gate, Qorvo, Whole Foods and More

Analysts' Actions -- Express Scripts, Lions Gate, Qorvo, Whole Foods and More

Here are Friday's top research calls, including upgrades for Express Scripts and Lions Gate, and downgrades for Qorvo and Whole Foods.

Insulet To Webcast Investor Day On November 16, 2016

Insulet To Webcast Investor Day On November 16, 2016

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced it will host an Investor Day on November...

Insulet Reports Third Quarter 2016 Financial Results

Insulet Reports Third Quarter 2016 Financial Results

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced financial results for...

New Study Shows Majority Of Omnipod® Insulin Management System Users Report Significant Clinical And Quality Of Life Benefits

New Study Shows Majority Of Omnipod® Insulin Management System Users Report Significant Clinical And Quality Of Life Benefits

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced the online publication...

Insulet Corporation Honors National Diabetes Awareness Month At The NASDAQ Stock Market Closing Bell Ceremony On November 1st

Insulet Corporation Honors National Diabetes Awareness Month At The NASDAQ Stock Market Closing Bell Ceremony On November 1st

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced it is kicking off...